TNGX - Tango Therapeutics GAAP EPS of -$0.29 misses by $0.01 revenue of $5.76M misses by $0.07M May, 11 2022 07:42 AM Tango Therapeutics Inc. Tango Therapeutics press release (NASDAQ:TNGX): Q1 GAAP EPS of -$0.29 misses by $0.01. Revenue of $5.76M (-9.9% Y/Y) misses by $0.07M. For further details see: Tango Therapeutics GAAP EPS of -$0.29 misses by $0.01, revenue of $5.76M misses by $0.07M